ID: h-f6caa52a3c
Hypothesis
Pharmacologic modulation of D2 autoreceptor-Gi/o signaling in established PD models
Test whether carefully titrated D2-pathway modulation can normalize pathological autoreceptor signaling after alpha-synuclein pathology is established.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 5 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Test whether carefully titrated D2-pathway modulation can normalize pathological autoreceptor signaling after alpha-synuclein pathology is established. The current debate supports this only as a mechanistic probe with direct electrophysiology and dopamine-release readouts, not yet as a strong therapeutic program.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["SNCA Alpha-Synuclein<br/>Presynaptic Protein"]
B["SNCA Misfolding<br/>Environmental Stress"]
C["SNCA Oligomers<br/>Toxic Protofibrils"]
D["Mitochondrial Pore<br/>Membrane Disruption"]
E["Lewy Body Formation<br/>Cytoplasmic Inclusions"]
F["Dopaminergic Neuron<br/>Dysfunction/Death"]
G["Nigrostriatal Degeneration<br/>Motor Symptoms"]
H["SNCA A53T/A30P/E46K<br/>Familial PD Mutations"]
A --> B
B --> C
C --> D
C --> E
D --> F
E --> F
F --> G
H -.->|"accelerates"| B
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8⚖️ Evidence
⚖️ Evidence Matrix5 supports3 contradicts
Supports
RGS6 deficiency is associated with hyperactive D2 autoreceptor signaling, so D2-Gi/o normalization remains a plausible downstream mechanism to test directly.
Supports
Conditional D2 autoreceptor loss can increase vulnerability in some toxin models, supporting a context-dependent role for autoreceptor signaling in dopaminergic resilience.
Supports
cAMP-mediated upregulation of HCN channels in VTA dopamine neurons promotes cocaine reinforcement.
Supports
Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.
Supports
Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens.
Contradicts
D2 agonism generally suppresses firing and dopamine release, so symptomatic pharmacology does not imply disease modification or neuroprotection.
Contradicts
Conditional D2 autoreceptor loss did not increase vulnerability in alpha-synuclein overexpression models, arguing against a simple rule that more D2 tone is protective across PD paradigms.
Contradicts
Pardoprunox and related compounds are not clean autoreceptor-selective tools, making interpretation vulnerable to off-target serotonergic and postsynaptic D2 effects.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — DRD2
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for DRD2 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for DRD2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.4%
Volatility
Low
0.0134
Events (7d)
2
Price History
▲11.2%💾 Resource Usage
LLM Tokens
11,782
$0.0353
Total Cost
$0.0353
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF a low-dose D2 dopamine receptor agonist (e.g., quinpirole 0.01-0.1 mg/kg, sc) is administered to rats with established alpha-synuclein pathology (≥8 weeks post-rAAV-αSyn injection in substantia nig | Restoration of regular, non-bursting firing pattern in ≥70% of recorded dopaminergic neurons, with firing rate returning to within 1 SD of age-matched control v | — no observation — | pending | 0.35 |
| IF a Gi/o-biased D2 autoreceptor positive allosteric modulator (PAM) is administered chronically (once daily, 14 days) to mice with established alpha-synuclein pathology (≥6 months post Thy1-αSyn tran | Striatal dopamine release amplitude increasing by ≥40% toward WT baseline, with full restoration of the D2 agonist (quinpirole 0.3 mg/kg)-mediated % inhibition | — no observation — | pending | 0.28 |
🔮 Falsifiable Predictions (2)
pendingconf 35%
IF a low-dose D2 dopamine receptor agonist (e.g., quinpirole 0.01-0.1 mg/kg, sc) is administered to rats with established alpha-synuclein pathology (≥8 weeks post-rAAV-αSyn injection in substantia nigra) THEN the irregular burst-firing pattern of identified SNc dopaminergic neurons will normalize to
Predicted outcome: Restoration of regular, non-bursting firing pattern in ≥70% of recorded dopaminergic neurons, with firing rate returning to within 1 SD of age-matched
Falsification: Firing rate and pattern remain statistically indistinguishable from vehicle-treated αSyn rats (persistent irregular bursting >50% of spikes in bursts, rate <3 Hz); or firing becomes completely suppres
pendingconf 28%
IF a Gi/o-biased D2 autoreceptor positive allosteric modulator (PAM) is administered chronically (once daily, 14 days) to mice with established alpha-synuclein pathology (≥6 months post Thy1-αSyn transgenic expression) THEN striatal dopamine release amplitude and the D2 autoreceptor-mediated inhibit
Predicted outcome: Striatal dopamine release amplitude increasing by ≥40% toward WT baseline, with full restoration of the D2 agonist (quinpirole 0.3 mg/kg)-mediated % i
Falsification: No statistically significant increase in evoked dopamine overflow (change <20% from vehicle baseline); or autoreceptor-mediated inhibition remains absent/blunted (<20% inhibition), indicating failure
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.